Nieuwoudt Stacy Durbin reported grant involving 5,100 derivative units of ASPEN AEROGELS INC at $0.00 for $0 on Nov 4, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 6, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
5,100Stock Options (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
5,100Direct
Trade date
Nov 4, 2026Grant
Filed
Nov 6, 2026, 4:30 PM ET2-day reporting delay
Accession
0001843185-26-000008Code A · Transaction 394908
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 4, 2026Grant6,073$0.00$0Trade 394907
2 transaction rows in this filing. Joint filers share the same rows.

ASPN price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ASPN · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +13%1w ago +8.9%1d ago 0%
Returns since7d +10%30d90d180d1y

Footnotes in full

F1: The reporting person was granted Restricted Stock Units ("RSUs") representing a portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. Each RSU represents the right to receive one share of Common Stock upon vesting. These RSUs will vest on the earlier of (a) May 13, 2027, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2027. F2: The reporting person was granted options representing the remaining portion of the annual grant of equity for service as a non-employee director pursuant to the Issuer's Non-Employee Director Compensation Policy. The options will vest on the earlier of (a) May 13, 2027, or (b) the day prior to the Issuer's annual meeting of stockholders to be held in 2027.